Surviving a Trump Meeting Doesn't Mean All Clear for Drug Industry

A relatively calm meeting with President Trump doesn’t eliminate drug-pricing risks.

from WSJ.com: Markets http://ift.tt/2jzBiEh
via https://ifttt.com/ IFTTT